Bogle Investment Management’s Charles River Laboratories CRL Stock Holding History

Bogle Investment Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-3,289	Closed	-$249K	–	402
2016 Q1	$249K	Buy	+3,289	New	+$243K	0.02%	358
2014 Q3	–	Sell	-159,459	Closed	-$8.53M	–	358
2014 Q2	$8.53M	Sell	159,459 -55,346	-26%	-$3.04M	0.57%	75
2014 Q1	$13M	Buy	214,805 +187,917	+699%	+$11M	0.89%	15
2013 Q4	$1.43M	Sell	26,888 -144,273	-84%	-$7.25M	0.12%	206
2013 Q3	$7.92M	Sell	171,161 -23,774	-12%	-$1.09M	0.8%	32
2013 Q2	$8M	Buy	+194,935	New	+$8.35M	0.98%	10

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Bogle Investment Management's CRL Position: Q2 2016 in Review

Bogle Investment Management sold out of Charles River Laboratories (CRL) in Q2 2016, closing a stake of 3,289 shares — an estimated $249K sold.

Bogle Investment Management first reported a position in CRL in Q2 2013 and held it in 6 quarters. The position peaked at $13M in Q1 2014. 286 funds tracked by Wall St. Rank hold CRL as of Q2 2016.

Bogle Investment Management reported no remaining Charles River Laboratories position as of Q2 2016 after selling out during the quarter.
Bogle Investment Management sold 3,289 Charles River Laboratories shares in Q2 2016, an estimated $249K.
Bogle Investment Management first reported a position in Charles River Laboratories in Q2 2013 and held it in 6 quarters.
Bogle Investment Management's Charles River Laboratories position peaked at $13M in Q1 2014.
286 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2016.

Based on Bogle Investment Management's 13F filing for Q2 2016, filed 12 Aug 2016.